{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Mean Study Distance\n",
    "\n",
    "Compute the mean similarity between studies which were included in each drug review and the studies which were explicitly excluded. The hope is that that the mean distance between studies in the same review is smaller than the mean distance to studies which were explicitly excluded!"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Choose Experiment Group & ID"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "exp_group = 'big-populations'\n",
    "exp_id = 9"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Load Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Using Theano backend.\n"
     ]
    }
   ],
   "source": [
    "import keras\n",
    "\n",
    "model = keras.models.load_model('store/weights/{}/{}/0-loss.h5'.format(exp_group, exp_id))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Load abstracts which were included and excluded at the PICO level..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>drug</th>\n",
       "      <th>label</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10023943</td>\n",
       "      <td>BetaBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>In patients with heart failure, beta-blockade ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10024259</td>\n",
       "      <td>ProtonPumpInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>To assess intermittent treatment over 12 month...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>10029645</td>\n",
       "      <td>ACEInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>Population-based studies have found that black...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10029786</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>Preterm labor is the leading cause of perinata...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>10030097</td>\n",
       "      <td>BetaBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Prospective, randomized and long term multicen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>10047626</td>\n",
       "      <td>Statins</td>\n",
       "      <td>inc</td>\n",
       "      <td>The HMG CoA reductase inhibitors have quickly ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>10052772</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The prevalence of gingival overgrowth induced ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>10063787</td>\n",
       "      <td>BetaBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>To assess the efficacy and safety of bisoprolo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>10066996</td>\n",
       "      <td>ADHD</td>\n",
       "      <td>inc</td>\n",
       "      <td>Three experiments were conducted to explore th...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>10069685</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>We compared antihypertensive efficacy and safe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>10071708</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>There is relatively little information regardi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>10072410</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>Drug-induced psychosis is a difficult problem ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>10072664</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>There is little information regarding the effe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>10073329</td>\n",
       "      <td>UrinaryIncontinence</td>\n",
       "      <td>inc</td>\n",
       "      <td>Oxybutynin is used for the treatment of urge u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>10073846</td>\n",
       "      <td>ACEInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>Patients with acute myocardial infarction and ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>10073852</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>This multicenter, randomized, double-blind, pa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>10075142</td>\n",
       "      <td>Statins</td>\n",
       "      <td>inc</td>\n",
       "      <td>The 3-hydroxy-3-methylglutaryl coenzyme A (HMG...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>10078088</td>\n",
       "      <td>ACEInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>To measure quality of life (QOL) in patients w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>10078501</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>We examined relapse after response to a first ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>10080412</td>\n",
       "      <td>BetaBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>In a double-blind, randomized, 3-month multice...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>10080457</td>\n",
       "      <td>ACEInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>Estimate the effect of angiotensin converting ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>10082075</td>\n",
       "      <td>ProtonPumpInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>Lansoprazole has undergone extensive clinical ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>10082152</td>\n",
       "      <td>OralHypoglycemics</td>\n",
       "      <td>inc</td>\n",
       "      <td>The increased tolerance to myocardial ischaemi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>10084637</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>We report the findings from the first large, d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>10088066</td>\n",
       "      <td>ACEInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>The RIMA (Rimodellamento Infarto Miocardico Ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>10090111</td>\n",
       "      <td>BetaBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Concern based on the reported short-term adver...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>10090348</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>A single-center, prospective double-blind rand...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>10090440</td>\n",
       "      <td>Antihistamines</td>\n",
       "      <td>inc</td>\n",
       "      <td>In a multicenter, parallel-group, double-maske...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>10091815</td>\n",
       "      <td>Statins</td>\n",
       "      <td>inc</td>\n",
       "      <td>The purpose of the study was to assess the eff...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>10097930</td>\n",
       "      <td>OralHypoglycemics</td>\n",
       "      <td>inc</td>\n",
       "      <td>Repaglinide is a newly developed oral blood gl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3071</th>\n",
       "      <td>9874808</td>\n",
       "      <td>NSAIDS</td>\n",
       "      <td>outcome</td>\n",
       "      <td>Prostaglandins (PG) are synthesized by two iso...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3072</th>\n",
       "      <td>9875725</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>outcome</td>\n",
       "      <td>Psilocybin, an indoleamine hallucinogen, produ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3073</th>\n",
       "      <td>9877016</td>\n",
       "      <td>Triptans</td>\n",
       "      <td>pop</td>\n",
       "      <td>The non-selective serotonin (5-HT) receptor ag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3074</th>\n",
       "      <td>9880123</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>A recent study suggested that the risk of all ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3075</th>\n",
       "      <td>9884683</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>pop</td>\n",
       "      <td>As can be discerned from this article, antipsy...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3076</th>\n",
       "      <td>9885782</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>outcome</td>\n",
       "      <td>Elevated plasma norepinephrine (NE) levels is ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3077</th>\n",
       "      <td>9888613</td>\n",
       "      <td>Triptans</td>\n",
       "      <td>pop</td>\n",
       "      <td>The novel selective 5-hydroxytryptamine (5-HT)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3078</th>\n",
       "      <td>9889429</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Thirteen psoriatic patients with hypertension ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3079</th>\n",
       "      <td>9890389</td>\n",
       "      <td>BetaBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The role of cocaine in cardiac ischemia and su...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3080</th>\n",
       "      <td>9890408</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>The aim of this study was to analyze whether, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3081</th>\n",
       "      <td>9892301</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>It has been hypothesized that the morbidity an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3082</th>\n",
       "      <td>9892302</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>pop</td>\n",
       "      <td>This study compared the effect of clozapine an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3083</th>\n",
       "      <td>9892879</td>\n",
       "      <td>ProtonPumpInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>Rabeprazole sodium is the most recent member o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3084</th>\n",
       "      <td>9916613</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>outcome</td>\n",
       "      <td>This study compared the drug-utilization costs...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3085</th>\n",
       "      <td>9921698</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>This article reviews the published clinical ex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3086</th>\n",
       "      <td>9922821</td>\n",
       "      <td>Triptans</td>\n",
       "      <td>inc</td>\n",
       "      <td>Cost-effectiveness and cost per successful tre...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3087</th>\n",
       "      <td>9928753</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>In this multicentre, double-blind, parallel-gr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3088</th>\n",
       "      <td>9930385</td>\n",
       "      <td>ProtonPumpInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>Lansoprazole (LAN) and omeprazole (OME) heal e...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3089</th>\n",
       "      <td>9930595</td>\n",
       "      <td>Antihistamines</td>\n",
       "      <td>inc</td>\n",
       "      <td>The aim of this study was to evaluate the in v...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3090</th>\n",
       "      <td>9931077</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>-Our objective was to compare cardiovascular e...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3091</th>\n",
       "      <td>9934729</td>\n",
       "      <td>ProtonPumpInhibitors</td>\n",
       "      <td>inc</td>\n",
       "      <td>The relationship between cholecystectomy and t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3092</th>\n",
       "      <td>9951950</td>\n",
       "      <td>Antihistamines</td>\n",
       "      <td>inc</td>\n",
       "      <td>Second-generation histamine H1 receptor antago...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3093</th>\n",
       "      <td>9972386</td>\n",
       "      <td>Triptans</td>\n",
       "      <td>pop</td>\n",
       "      <td>To review medication-induced headache (MIH) th...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3094</th>\n",
       "      <td>9973007</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>We compared the effects of five pharmacologic ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3095</th>\n",
       "      <td>9987697</td>\n",
       "      <td>Triptans</td>\n",
       "      <td>pop</td>\n",
       "      <td>Migraine is a common disorder that causes sign...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3096</th>\n",
       "      <td>9988841</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>The objective of this meta-analysis is to summ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097</th>\n",
       "      <td>9989534</td>\n",
       "      <td>BetaBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Multiple models explaining the pathogenesis of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3098</th>\n",
       "      <td>9989540</td>\n",
       "      <td>OralHypoglycemics</td>\n",
       "      <td>inc</td>\n",
       "      <td>Hypoglycemic coma is a continuous threat for d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3099</th>\n",
       "      <td>9989566</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>Clozapine and risperidone were the first two \"...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3100</th>\n",
       "      <td>9989571</td>\n",
       "      <td>AtypicalAntipsychotics</td>\n",
       "      <td>inc</td>\n",
       "      <td>Leptin is produced by fat cells and is presume...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3101 rows Ã— 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          pmid                    drug    label  \\\n",
       "0     10023943            BetaBlockers      inc   \n",
       "1     10024259    ProtonPumpInhibitors      inc   \n",
       "2     10029645           ACEInhibitors      inc   \n",
       "3     10029786  CalciumChannelBlockers      pop   \n",
       "4     10030097            BetaBlockers      inc   \n",
       "5     10047626                 Statins      inc   \n",
       "6     10052772  CalciumChannelBlockers      inc   \n",
       "7     10063787            BetaBlockers      inc   \n",
       "8     10066996                    ADHD      inc   \n",
       "9     10069685  CalciumChannelBlockers  outcome   \n",
       "10    10071708  AtypicalAntipsychotics      inc   \n",
       "11    10072410  AtypicalAntipsychotics      inc   \n",
       "12    10072664  AtypicalAntipsychotics      inc   \n",
       "13    10073329     UrinaryIncontinence      inc   \n",
       "14    10073846           ACEInhibitors      inc   \n",
       "15    10073852  CalciumChannelBlockers      inc   \n",
       "16    10075142                 Statins      inc   \n",
       "17    10078088           ACEInhibitors      inc   \n",
       "18    10078501  AtypicalAntipsychotics      inc   \n",
       "19    10080412            BetaBlockers      inc   \n",
       "20    10080457           ACEInhibitors      inc   \n",
       "21    10082075    ProtonPumpInhibitors      inc   \n",
       "22    10082152       OralHypoglycemics      inc   \n",
       "23    10084637  AtypicalAntipsychotics      inc   \n",
       "24    10088066           ACEInhibitors      inc   \n",
       "25    10090111            BetaBlockers      inc   \n",
       "26    10090348  CalciumChannelBlockers  outcome   \n",
       "27    10090440          Antihistamines      inc   \n",
       "28    10091815                 Statins      inc   \n",
       "29    10097930       OralHypoglycemics      inc   \n",
       "...        ...                     ...      ...   \n",
       "3071   9874808                  NSAIDS  outcome   \n",
       "3072   9875725  AtypicalAntipsychotics  outcome   \n",
       "3073   9877016                Triptans      pop   \n",
       "3074   9880123  CalciumChannelBlockers      inc   \n",
       "3075   9884683  AtypicalAntipsychotics      pop   \n",
       "3076   9885782  AtypicalAntipsychotics  outcome   \n",
       "3077   9888613                Triptans      pop   \n",
       "3078   9889429  CalciumChannelBlockers      inc   \n",
       "3079   9890389            BetaBlockers      inc   \n",
       "3080   9890408  CalciumChannelBlockers  outcome   \n",
       "3081   9892301  AtypicalAntipsychotics      inc   \n",
       "3082   9892302  AtypicalAntipsychotics      pop   \n",
       "3083   9892879    ProtonPumpInhibitors      inc   \n",
       "3084   9916613  AtypicalAntipsychotics  outcome   \n",
       "3085   9921698  AtypicalAntipsychotics      inc   \n",
       "3086   9922821                Triptans      inc   \n",
       "3087   9928753  CalciumChannelBlockers  outcome   \n",
       "3088   9930385    ProtonPumpInhibitors      inc   \n",
       "3089   9930595          Antihistamines      inc   \n",
       "3090   9931077  CalciumChannelBlockers      inc   \n",
       "3091   9934729    ProtonPumpInhibitors      inc   \n",
       "3092   9951950          Antihistamines      inc   \n",
       "3093   9972386                Triptans      pop   \n",
       "3094   9973007  CalciumChannelBlockers      inc   \n",
       "3095   9987697                Triptans      pop   \n",
       "3096   9988841  AtypicalAntipsychotics      inc   \n",
       "3097   9989534            BetaBlockers      inc   \n",
       "3098   9989540       OralHypoglycemics      inc   \n",
       "3099   9989566  AtypicalAntipsychotics      inc   \n",
       "3100   9989571  AtypicalAntipsychotics      inc   \n",
       "\n",
       "                                                   text  \n",
       "0     In patients with heart failure, beta-blockade ...  \n",
       "1     To assess intermittent treatment over 12 month...  \n",
       "2     Population-based studies have found that black...  \n",
       "3     Preterm labor is the leading cause of perinata...  \n",
       "4     Prospective, randomized and long term multicen...  \n",
       "5     The HMG CoA reductase inhibitors have quickly ...  \n",
       "6     The prevalence of gingival overgrowth induced ...  \n",
       "7     To assess the efficacy and safety of bisoprolo...  \n",
       "8     Three experiments were conducted to explore th...  \n",
       "9     We compared antihypertensive efficacy and safe...  \n",
       "10    There is relatively little information regardi...  \n",
       "11    Drug-induced psychosis is a difficult problem ...  \n",
       "12    There is little information regarding the effe...  \n",
       "13    Oxybutynin is used for the treatment of urge u...  \n",
       "14    Patients with acute myocardial infarction and ...  \n",
       "15    This multicenter, randomized, double-blind, pa...  \n",
       "16    The 3-hydroxy-3-methylglutaryl coenzyme A (HMG...  \n",
       "17    To measure quality of life (QOL) in patients w...  \n",
       "18    We examined relapse after response to a first ...  \n",
       "19    In a double-blind, randomized, 3-month multice...  \n",
       "20    Estimate the effect of angiotensin converting ...  \n",
       "21    Lansoprazole has undergone extensive clinical ...  \n",
       "22    The increased tolerance to myocardial ischaemi...  \n",
       "23    We report the findings from the first large, d...  \n",
       "24    The RIMA (Rimodellamento Infarto Miocardico Ac...  \n",
       "25    Concern based on the reported short-term adver...  \n",
       "26    A single-center, prospective double-blind rand...  \n",
       "27    In a multicenter, parallel-group, double-maske...  \n",
       "28    The purpose of the study was to assess the eff...  \n",
       "29    Repaglinide is a newly developed oral blood gl...  \n",
       "...                                                 ...  \n",
       "3071  Prostaglandins (PG) are synthesized by two iso...  \n",
       "3072  Psilocybin, an indoleamine hallucinogen, produ...  \n",
       "3073  The non-selective serotonin (5-HT) receptor ag...  \n",
       "3074  A recent study suggested that the risk of all ...  \n",
       "3075  As can be discerned from this article, antipsy...  \n",
       "3076  Elevated plasma norepinephrine (NE) levels is ...  \n",
       "3077  The novel selective 5-hydroxytryptamine (5-HT)...  \n",
       "3078  Thirteen psoriatic patients with hypertension ...  \n",
       "3079  The role of cocaine in cardiac ischemia and su...  \n",
       "3080  The aim of this study was to analyze whether, ...  \n",
       "3081  It has been hypothesized that the morbidity an...  \n",
       "3082  This study compared the effect of clozapine an...  \n",
       "3083  Rabeprazole sodium is the most recent member o...  \n",
       "3084  This study compared the drug-utilization costs...  \n",
       "3085  This article reviews the published clinical ex...  \n",
       "3086  Cost-effectiveness and cost per successful tre...  \n",
       "3087  In this multicentre, double-blind, parallel-gr...  \n",
       "3088  Lansoprazole (LAN) and omeprazole (OME) heal e...  \n",
       "3089  The aim of this study was to evaluate the in v...  \n",
       "3090  -Our objective was to compare cardiovascular e...  \n",
       "3091  The relationship between cholecystectomy and t...  \n",
       "3092  Second-generation histamine H1 receptor antago...  \n",
       "3093  To review medication-induced headache (MIH) th...  \n",
       "3094  We compared the effects of five pharmacologic ...  \n",
       "3095  Migraine is a common disorder that causes sign...  \n",
       "3096  The objective of this meta-analysis is to summ...  \n",
       "3097  Multiple models explaining the pathogenesis of...  \n",
       "3098  Hypoglycemic coma is a continuous threat for d...  \n",
       "3099  Clozapine and risperidone were the first two \"...  \n",
       "3100  Leptin is produced by fat cells and is presume...  \n",
       "\n",
       "[3101 rows x 4 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv('../preprocess/test_df.csv')\n",
    "\n",
    "df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### List Drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ACEInhibitors\n",
      "ADHD\n",
      "Antihistamines\n",
      "AtypicalAntipsychotics\n",
      "BetaBlockers\n",
      "CalciumChannelBlockers\n",
      "Estrogens\n",
      "NSAIDS\n",
      "Opiods\n",
      "OralHypoglycemics\n",
      "ProtonPumpInhibitors\n",
      "SkeletalMuscleRelaxants\n",
      "Statins\n",
      "Triptans\n",
      "UrinaryIncontinence\n"
     ]
    }
   ],
   "source": [
    "for drug in df.groupby('drug').size().index.tolist():\n",
    "    print drug"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Sample Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "To determine whether a third generation vasodilating beta blocker (celiprolol) has long term clinical advantages over metoprolol in patients with chronic heart failure.\n",
      "\n",
      "********************************************************************************\n",
      "This article has reviewed the emerging side-effect profiles of second-generation antipsychotic medications. Although these medications have favorable extrapyramidal side-effect profiles, clinicians must be aware of their propensity to cause weight gain, glucose and lipid abnormalities, and cardiac and sexual side effects. If clinicians are proactive about warning patients about these side effects and appropriately monitoring them, further morbidity and mortality may be prevented in this patient population. Initial choices of medication should be made based on the relative side-effect profiles in light of a particular patient's medical status. In the future, new treatments may be developed, with even fewer side effects.\n",
      "\n",
      "********************************************************************************\n",
      "This review examines the evidence for the development of adverse effects due to prolonged gastric acid suppression with proton pump inhibitors. Potential areas of concern regarding long-term proton pump inhibitor use have included: carcinoid formation; development of gastric adenocarcinoma (especially in patients with Helicobacter pylori infection); bacterial overgrowth; enteric infections; and malabsorption of fat, minerals, and vitamins. Prolonged proton pump inhibitor use may lead to enterochromaffin-like cell hyperplasia, but has not been demonstrated to increase the risk of carcinoid formation. Long-term proton pump inhibitor treatment has not been documented to hasten the development or the progression of atrophic gastritis to intestinal metaplasia and gastric cancer, although long-term studies are required to allow definitive conclusions. At present, we do not recommend that patients be tested routinely for H. pylori infection when using proton pump inhibitors for prolonged periods. Gastric bacterial overgrowth does increase with acid suppression, but important clinical sequelae, such a higher rate of gastric adenocarcinoma, have not been seen. The risk of enteric infection may increase with acid suppression, although this does not seem to be a common clinical problem with prolonged proton pump inhibitor use. The absorption of fats and minerals does not appear to be significantly impaired with chronic acid suppression. However, vitamin B12 concentration may be decreased when gastric acid is markedly suppressed for prolonged periods (e.g. Zolllinger-Ellison syndrome), and vitamin B12 levels should probably be assessed in patients taking high-dose proton pump inhibitors for many years. Thus, current evidence suggests that prolonged gastric acid suppression with proton pump inhibitors rarely, if ever, produces adverse events. Nevertheless, continued follow-up of patients taking proton pump inhibitors for extended periods will provide greater experience regarding the potential gastrointestinal adverse effects of long-term acid suppression.\n",
      "\n",
      "********************************************************************************\n",
      "Diabetic nephropathy is the most common cause of end-stage renal disease in the United States. We undertook a study to assess the impact of assignment to different levels of blood pressure control on the course of type 1 diabetic nephropathy in patients receiving angiotensin-converting enzyme (ACE) inhibitor therapy. We also examined the long-term course of this well-characterized cohort of patients receiving ACE inhibitor therapy. One hundred twenty-nine patients with type 1 diabetes and diabetic nephropathy who had previously participated in the Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy Study who had a serum creatinine level less than 4.0 mg/dL were randomly assigned to a mean arterial blood pressure (MAP) goal of 92 mm Hg or less (group I) or 100 to 107 mm Hg (group II). Patients received varying doses of ramipril as the primary therapeutic antihypertensive agent. All patients were followed for a minimum of 2 years. Outcome measures included iothalamate clearance, 24-hour creatinine clearance, creatinine clearance estimated by the Cockcroft and Gault formula, and urinary protein excretion. The average difference in MAP between groups was 6 mm Hg over the 24-month follow-up. The median iothalamate clearance in group I was 62 mL/min/1.73 m(2) at baseline and 54 mL/min/1.73 m(2) at the end of the study compared with a baseline of 64 mL/min/1.73 m(2) and final 58 mL/min/1.73 m(2) in group II. There were no statistically significant differences in the rate of decline in renal function between groups. There was a significant difference in follow-up total urinary protein excretion between group I (535 mg/24 h) and group II (1,723 mg/24 h; P = 0.02). Thirty-two percent of 126 patients achieved a final total protein excretion less than 500 mg/24 h. Patients from groups I and II had equivalent rates of adverse events. In patients with type 1 diabetes mellitus and diabetic nephropathy, the MAP goal should be 92 mm Hg or less for optimal renoprotection, if defined as including decreased proteinuria. With the combination of ACE inhibition and intensive blood pressure control, many patients can achieve regression or apparent remission of clinical evidence of diabetic nephropathy.\n",
      "\n",
      "********************************************************************************\n",
      "The use of lipid-altering drugs has been shown to reduce the progression of atherosclerotic lesions and reduce the risk of atherosclerotic events (such as myocardial infarction and stroke). In general, these lipid-altering drugs are well tolerated but there is the potential for drug interactions. For example, HMG-CoA reductase inhibitors may interact with macrolides, azalides, azole antifungals and cyclosporin. Resins (such as cholestyramine and colestipol) may impair the absorption of many concurrent medications. Fibrates have potential drug interactions with warfarin, furosemide (frusemide), oral hypoglycaemics and probenecid. Nicotinic acid (niacin) may have potential drug interactions with high dose aspirin (acetylsalicylic acid), uricosuric agents (such as sulfapyrazone) and alcohol (ethanol). Finally, probucol may have potential drug interactions with antidysrhythmics, tricyclic antidepressants and phenothiazines. In addition, lipid-altering drugs, used in combination, may have the potential for drug interactions, enhancing some of the risks of adverse effects, such as myositis and hepatotoxicity. Therefore, in order to use lipid-altering drugs in the most effective, and safest manner, it is important for the clinician to have an understanding of the mechanisms of potential drug interactions, which drug interactions may theoretically occur, and specifically, which spe cific drug interactions have already been described.\n",
      "\n",
      "********************************************************************************\n"
     ]
    }
   ],
   "source": [
    "for _ in range(5):\n",
    "    print np.random.choice(df.text)\n",
    "    print\n",
    "    print '*'*80"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Check drug categories..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ACEInhibitors\n",
      "label\n",
      "inc        168\n",
      "outcome      2\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "ADHD\n",
      "label\n",
      "inc        83\n",
      "outcome    21\n",
      "pop         4\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "Antihistamines\n",
      "label\n",
      "inc    90\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "AtypicalAntipsychotics\n",
      "label\n",
      "inc        333\n",
      "outcome    120\n",
      "pop         94\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "BetaBlockers\n",
      "label\n",
      "inc        270\n",
      "outcome      8\n",
      "pop         53\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "CalciumChannelBlockers\n",
      "label\n",
      "inc        257\n",
      "outcome    145\n",
      "pop         94\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "Estrogens\n",
      "label\n",
      "inc    79\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "NSAIDS\n",
      "label\n",
      "inc        83\n",
      "outcome    14\n",
      "pop        90\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "Opiods\n",
      "label\n",
      "inc        43\n",
      "outcome     4\n",
      "pop        21\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "OralHypoglycemics\n",
      "label\n",
      "inc        135\n",
      "outcome      6\n",
      "pop          1\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "ProtonPumpInhibitors\n",
      "label\n",
      "inc        227\n",
      "outcome     23\n",
      "pop          6\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "SkeletalMuscleRelaxants\n",
      "label\n",
      "inc        30\n",
      "outcome    23\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "Statins\n",
      "label\n",
      "inc    152\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "Triptans\n",
      "label\n",
      "inc        205\n",
      "outcome     44\n",
      "pop         96\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n",
      "UrinaryIncontinence\n",
      "label\n",
      "inc    68\n",
      "pop     9\n",
      "dtype: int64\n",
      "\n",
      "********************************************************************************\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for name, group in df.groupby('drug'):\n",
    "    print name\n",
    "    print group.groupby('label').size()\n",
    "    print\n",
    "    print '*'*80\n",
    "    print"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "CalciumChannelBlockers seems to have a somewhat uniform distribution. Let's go with that..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>drug</th>\n",
       "      <th>label</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10029786</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>Preterm labor is the leading cause of perinata...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>10052772</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The prevalence of gingival overgrowth induced ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>10069685</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>We compared antihypertensive efficacy and safe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>10073852</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>This multicenter, randomized, double-blind, pa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>10090348</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>A single-center, prospective double-blind rand...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>10099034</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>It has been proposed that worsening of heart f...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>10099075</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>To assess the efficacy and safety of 2.5, 5, a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>10100063</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The Systolic Hypertension in Europe (Syst-Eur)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>10172139</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>This study was a prospective observational stu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>10189144</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Recent reports suggest a possible link between...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>10197663</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>We assessed the efficacy of a continuous infus...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>10203199</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>To determine the symptomatic well-being of eld...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>10218748</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>To examine whether the degree of stress associ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>10220634</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The primary objective of this randomized, doub...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>10321444</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>This study compared the antihypertensive effic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>10323641</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Recent studies have highlighted the potentiall...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>10336572</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The combination of calcium channel blockers an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>10355070</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>Atrial fibrillation (AF) is the most frequent ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>10378820</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The combination of calcium channel blockers an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>10417501</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Some reports have suggested that calcium chann...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>10433352</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>Prematurity is the leading cause of neonatal m...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>10449212</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>Nitric oxide donors have been used in the mana...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>10449213</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>Fixed-dose combination antihypertensive therap...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>10454779</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>We designed a study to determine the efficacy ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>192</th>\n",
       "      <td>10457878</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>Changes in heart rate, systolic, diastolic and...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227</th>\n",
       "      <td>10513787</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The effects of a beta blocker (atenolol), a ca...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>10535341</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>Since large randomized clinical trials compari...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>10545432</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Atrial fibrillation (AF) can be initiated by e...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>243</th>\n",
       "      <td>10547174</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Although calcium channel blockers are a useful...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>255</th>\n",
       "      <td>10562973</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>Hypertension (HTN) is a significant problem in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2919</th>\n",
       "      <td>9594859</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Perioperative administration of intravenous di...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2950</th>\n",
       "      <td>9683312</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The Controlled ONset Verapamil INvestigation o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2952</th>\n",
       "      <td>9684422</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>There have been important advances in the mana...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2955</th>\n",
       "      <td>9688432</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>We compared the effects of abrupt cessation of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2956</th>\n",
       "      <td>9688484</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>To compare the tocolytic efficacy and maternal...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2966</th>\n",
       "      <td>9700998</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>We compared the effects of cilnidipine and nif...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2973</th>\n",
       "      <td>9706857</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>The purpose of this study was to compare probi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2989</th>\n",
       "      <td>9727544</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Myocardial stunning may cause prolonged left v...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2990</th>\n",
       "      <td>9727772</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>In a subset of patients with primary pulmonary...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2991</th>\n",
       "      <td>9727842</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>The calcium channel blocker nifedipine is wide...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2997</th>\n",
       "      <td>9737514</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>Uncontrolled studies have suggested that atrio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2999</th>\n",
       "      <td>9739499</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>In animal and in vitro studies, several calciu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3001</th>\n",
       "      <td>9741502</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>This study was defined as a pilot investigatio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3015</th>\n",
       "      <td>9775988</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>The objective of this study was to compare the...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3019</th>\n",
       "      <td>9781971</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Investigations of calcium antagonists in patie...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3022</th>\n",
       "      <td>9785750</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>One hundred patients were tested prior to otol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3024</th>\n",
       "      <td>9790159</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>pop</td>\n",
       "      <td>Of 30 patients with treatment-refractory affec...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3027</th>\n",
       "      <td>9794714</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>To describe measures of quality of life of eld...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3028</th>\n",
       "      <td>9794736</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>To assess cognitive functions and their correl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3038</th>\n",
       "      <td>9806660</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Some studies have suggested that the use of ca...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3042</th>\n",
       "      <td>9809930</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The primary objective of the International Ver...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3048</th>\n",
       "      <td>9825197</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>The management of permanent atrial fibrillatio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3062</th>\n",
       "      <td>9856368</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>It is unclear whether the carotid intima-media...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3068</th>\n",
       "      <td>9869019</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Compliance with hypertension treatment is affe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3074</th>\n",
       "      <td>9880123</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>A recent study suggested that the risk of all ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3078</th>\n",
       "      <td>9889429</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>Thirteen psoriatic patients with hypertension ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3080</th>\n",
       "      <td>9890408</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>The aim of this study was to analyze whether, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3087</th>\n",
       "      <td>9928753</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>outcome</td>\n",
       "      <td>In this multicentre, double-blind, parallel-gr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3090</th>\n",
       "      <td>9931077</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>-Our objective was to compare cardiovascular e...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3094</th>\n",
       "      <td>9973007</td>\n",
       "      <td>CalciumChannelBlockers</td>\n",
       "      <td>inc</td>\n",
       "      <td>We compared the effects of five pharmacologic ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>496 rows Ã— 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          pmid                    drug    label  \\\n",
       "3     10029786  CalciumChannelBlockers      pop   \n",
       "6     10052772  CalciumChannelBlockers      inc   \n",
       "9     10069685  CalciumChannelBlockers  outcome   \n",
       "15    10073852  CalciumChannelBlockers      inc   \n",
       "26    10090348  CalciumChannelBlockers  outcome   \n",
       "30    10099034  CalciumChannelBlockers      inc   \n",
       "32    10099075  CalciumChannelBlockers  outcome   \n",
       "35    10100063  CalciumChannelBlockers      inc   \n",
       "50    10172139  CalciumChannelBlockers      inc   \n",
       "55    10189144  CalciumChannelBlockers      inc   \n",
       "60    10197663  CalciumChannelBlockers      pop   \n",
       "66    10203199  CalciumChannelBlockers      inc   \n",
       "74    10218748  CalciumChannelBlockers      inc   \n",
       "76    10220634  CalciumChannelBlockers      inc   \n",
       "88    10321444  CalciumChannelBlockers  outcome   \n",
       "89    10323641  CalciumChannelBlockers      inc   \n",
       "98    10336572  CalciumChannelBlockers      inc   \n",
       "107   10355070  CalciumChannelBlockers  outcome   \n",
       "127   10378820  CalciumChannelBlockers      inc   \n",
       "166   10417501  CalciumChannelBlockers      inc   \n",
       "174   10433352  CalciumChannelBlockers      pop   \n",
       "184   10449212  CalciumChannelBlockers  outcome   \n",
       "186   10449213  CalciumChannelBlockers  outcome   \n",
       "189   10454779  CalciumChannelBlockers      pop   \n",
       "192   10457878  CalciumChannelBlockers      pop   \n",
       "227   10513787  CalciumChannelBlockers      inc   \n",
       "236   10535341  CalciumChannelBlockers      pop   \n",
       "241   10545432  CalciumChannelBlockers      inc   \n",
       "243   10547174  CalciumChannelBlockers      inc   \n",
       "255   10562973  CalciumChannelBlockers      pop   \n",
       "...        ...                     ...      ...   \n",
       "2919   9594859  CalciumChannelBlockers      inc   \n",
       "2950   9683312  CalciumChannelBlockers      inc   \n",
       "2952   9684422  CalciumChannelBlockers  outcome   \n",
       "2955   9688432  CalciumChannelBlockers      inc   \n",
       "2956   9688484  CalciumChannelBlockers      pop   \n",
       "2966   9700998  CalciumChannelBlockers      inc   \n",
       "2973   9706857  CalciumChannelBlockers      pop   \n",
       "2989   9727544  CalciumChannelBlockers      inc   \n",
       "2990   9727772  CalciumChannelBlockers      pop   \n",
       "2991   9727842  CalciumChannelBlockers      pop   \n",
       "2997   9737514  CalciumChannelBlockers  outcome   \n",
       "2999   9739499  CalciumChannelBlockers      inc   \n",
       "3001   9741502  CalciumChannelBlockers      pop   \n",
       "3015   9775988  CalciumChannelBlockers      pop   \n",
       "3019   9781971  CalciumChannelBlockers      inc   \n",
       "3022   9785750  CalciumChannelBlockers  outcome   \n",
       "3024   9790159  CalciumChannelBlockers      pop   \n",
       "3027   9794714  CalciumChannelBlockers      inc   \n",
       "3028   9794736  CalciumChannelBlockers      inc   \n",
       "3038   9806660  CalciumChannelBlockers      inc   \n",
       "3042   9809930  CalciumChannelBlockers      inc   \n",
       "3048   9825197  CalciumChannelBlockers      inc   \n",
       "3062   9856368  CalciumChannelBlockers      inc   \n",
       "3068   9869019  CalciumChannelBlockers      inc   \n",
       "3074   9880123  CalciumChannelBlockers      inc   \n",
       "3078   9889429  CalciumChannelBlockers      inc   \n",
       "3080   9890408  CalciumChannelBlockers  outcome   \n",
       "3087   9928753  CalciumChannelBlockers  outcome   \n",
       "3090   9931077  CalciumChannelBlockers      inc   \n",
       "3094   9973007  CalciumChannelBlockers      inc   \n",
       "\n",
       "                                                   text  \n",
       "3     Preterm labor is the leading cause of perinata...  \n",
       "6     The prevalence of gingival overgrowth induced ...  \n",
       "9     We compared antihypertensive efficacy and safe...  \n",
       "15    This multicenter, randomized, double-blind, pa...  \n",
       "26    A single-center, prospective double-blind rand...  \n",
       "30    It has been proposed that worsening of heart f...  \n",
       "32    To assess the efficacy and safety of 2.5, 5, a...  \n",
       "35    The Systolic Hypertension in Europe (Syst-Eur)...  \n",
       "50    This study was a prospective observational stu...  \n",
       "55    Recent reports suggest a possible link between...  \n",
       "60    We assessed the efficacy of a continuous infus...  \n",
       "66    To determine the symptomatic well-being of eld...  \n",
       "74    To examine whether the degree of stress associ...  \n",
       "76    The primary objective of this randomized, doub...  \n",
       "88    This study compared the antihypertensive effic...  \n",
       "89    Recent studies have highlighted the potentiall...  \n",
       "98    The combination of calcium channel blockers an...  \n",
       "107   Atrial fibrillation (AF) is the most frequent ...  \n",
       "127   The combination of calcium channel blockers an...  \n",
       "166   Some reports have suggested that calcium chann...  \n",
       "174   Prematurity is the leading cause of neonatal m...  \n",
       "184   Nitric oxide donors have been used in the mana...  \n",
       "186   Fixed-dose combination antihypertensive therap...  \n",
       "189   We designed a study to determine the efficacy ...  \n",
       "192   Changes in heart rate, systolic, diastolic and...  \n",
       "227   The effects of a beta blocker (atenolol), a ca...  \n",
       "236   Since large randomized clinical trials compari...  \n",
       "241   Atrial fibrillation (AF) can be initiated by e...  \n",
       "243   Although calcium channel blockers are a useful...  \n",
       "255   Hypertension (HTN) is a significant problem in...  \n",
       "...                                                 ...  \n",
       "2919  Perioperative administration of intravenous di...  \n",
       "2950  The Controlled ONset Verapamil INvestigation o...  \n",
       "2952  There have been important advances in the mana...  \n",
       "2955  We compared the effects of abrupt cessation of...  \n",
       "2956  To compare the tocolytic efficacy and maternal...  \n",
       "2966  We compared the effects of cilnidipine and nif...  \n",
       "2973  The purpose of this study was to compare probi...  \n",
       "2989  Myocardial stunning may cause prolonged left v...  \n",
       "2990  In a subset of patients with primary pulmonary...  \n",
       "2991  The calcium channel blocker nifedipine is wide...  \n",
       "2997  Uncontrolled studies have suggested that atrio...  \n",
       "2999  In animal and in vitro studies, several calciu...  \n",
       "3001  This study was defined as a pilot investigatio...  \n",
       "3015  The objective of this study was to compare the...  \n",
       "3019  Investigations of calcium antagonists in patie...  \n",
       "3022  One hundred patients were tested prior to otol...  \n",
       "3024  Of 30 patients with treatment-refractory affec...  \n",
       "3027  To describe measures of quality of life of eld...  \n",
       "3028  To assess cognitive functions and their correl...  \n",
       "3038  Some studies have suggested that the use of ca...  \n",
       "3042  The primary objective of the International Ver...  \n",
       "3048  The management of permanent atrial fibrillatio...  \n",
       "3062  It is unclear whether the carotid intima-media...  \n",
       "3068  Compliance with hypertension treatment is affe...  \n",
       "3074  A recent study suggested that the risk of all ...  \n",
       "3078  Thirteen psoriatic patients with hypertension ...  \n",
       "3080  The aim of this study was to analyze whether, ...  \n",
       "3087  In this multicentre, double-blind, parallel-gr...  \n",
       "3090  -Our objective was to compare cardiovascular e...  \n",
       "3094  We compared the effects of five pharmacologic ...  \n",
       "\n",
       "[496 rows x 4 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_df = df.groupby('drug').get_group('CalciumChannelBlockers')\n",
    "\n",
    "drug_df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Load Population Vectorizer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "import pickle\n",
    "\n",
    "vectorizer = pickle.load(open('../preprocess/abstracts.p'))\n",
    "\n",
    "X = vectorizer.texts_to_sequences(drug_df.text)\n",
    "\n",
    "inc_idxs = np.argwhere(drug_df.label == 'inc').flatten()\n",
    "pop_idxs = np.argwhere(drug_df.label == 'pop').flatten()\n",
    "\n",
    "X_pop, X_inc = X[pop_idxs], X[inc_idxs]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Run abstracts through the model..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "import keras.backend as K\n",
    "\n",
    "inputs = [model.inputs[0], K.learning_phase()]\n",
    "outputs = model.get_layer('study').output\n",
    "f = K.function(inputs, outputs)\n",
    "\n",
    "TEST_MODE = 0\n",
    "H_pop, H_inc = f([X_pop, TEST_MODE]), f([X_inc, TEST_MODE])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Compute the mean similarity..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "def gen_upper_triangular(N=5):\n",
    "    \"\"\"Generate pairs of indexes to be passed to zip() so we can extract the upper triangle of a matrix\"\"\"\n",
    "    \n",
    "    for i in range(N):\n",
    "        for j in range(i+1, N):\n",
    "            yield i, j\n",
    "            \n",
    "I, J = zip(*list(gen_upper_triangular(N=len(H_inc))))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Mean similarity between studies which were included in the same review..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.37692174"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "S_inc = np.dot(H_inc, H_inc.T)\n",
    "\n",
    "S_inc[I, J].mean()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Mean similarity between studies which were included in the same review and studies which were excluded due to population..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.21857567"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "S_pop = np.dot(H_pop, H_inc.T)\n",
    "\n",
    "S_pop.mean()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Almost all activations are zero!"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "243"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "used_idxs = np.argwhere(H_inc != 0)[:, 1]\n",
    "\n",
    "np.unique(used_idxs).shape[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([ 0.998999  ,  0.98798799,  0.998999  ,  0.998999  ,  0.98398398,\n",
       "        0.99099099,  0.997998  ,  0.995996  ,  0.98998999,  0.98698699,\n",
       "        0.99299299,  0.997998  ,  0.98798799,  0.998999  ,  0.997998  ,\n",
       "        0.995996  ,  0.98198198,  0.996997  ,  0.996997  ,  0.99099099,\n",
       "        0.98898899,  0.997998  ,  0.99099099,  0.98598599,  0.99499499,\n",
       "        0.996997  ,  0.98598599,  0.98598599,  0.99199199,  0.99499499,\n",
       "        0.995996  ,  0.996997  ,  0.99399399,  1.        ,  0.99399399,\n",
       "        0.99499499,  0.996997  ,  0.998999  ,  0.998999  ,  0.998999  ,\n",
       "        0.995996  ,  0.98798799,  0.997998  ,  0.998999  ,  0.99499499,\n",
       "        0.98598599,  0.998999  ,  0.99299299,  0.995996  ,  0.998999  ,\n",
       "        1.        ,  0.998999  ,  0.96796797,  0.99199199,  0.995996  ,\n",
       "        0.99499499,  0.98998999,  0.97997998,  0.998999  ,  0.99499499,\n",
       "        0.998999  ,  0.995996  ,  0.996997  ,  0.995996  ,  0.99199199,\n",
       "        0.998999  ,  0.997998  ,  0.997998  ,  0.99299299,  0.98198198,\n",
       "        1.        ,  0.998999  ,  1.        ,  0.99499499,  1.        ,\n",
       "        0.98798799,  0.99499499,  0.996997  ,  1.        ,  0.998999  ,\n",
       "        0.997998  ,  0.99399399,  0.99399399,  0.99199199,  0.99499499,\n",
       "        0.98998999,  0.99299299,  0.96596597,  0.98798799,  0.998999  ,\n",
       "        0.99399399,  0.98998999,  0.996997  ,  0.99299299,  0.99399399,\n",
       "        0.98798799,  0.998999  ,  0.996997  ,  0.998999  ,  0.995996  ,\n",
       "        0.99299299,  0.996997  ,  0.99399399,  0.99199199,  1.        ,\n",
       "        0.995996  ,  0.995996  ,  0.998999  ,  0.997998  ,  0.995996  ,\n",
       "        0.997998  ,  1.        ,  1.        ,  1.        ,  0.98698699,\n",
       "        0.997998  ,  0.998999  ,  0.99299299,  0.996997  ,  1.        ,\n",
       "        0.995996  ,  0.998999  ,  0.997998  ,  0.98898899,  0.98098098,\n",
       "        0.99499499,  0.99399399,  0.995996  ,  0.99299299,  0.98598599,\n",
       "        1.        ,  0.996997  ,  0.99399399,  0.996997  ,  0.98998999,\n",
       "        0.998999  ,  0.997998  ,  0.997998  ,  0.97997998,  0.99099099,\n",
       "        0.998999  ,  0.995996  ,  1.        ,  0.995996  ,  0.99099099,\n",
       "        0.99399399,  0.98498498,  0.997998  ,  0.998999  ,  0.99399399,\n",
       "        0.996997  ,  0.99399399,  0.98998999,  0.99299299,  0.99399399,\n",
       "        0.998999  ,  0.995996  ,  0.99399399,  0.996997  ,  0.995996  ,\n",
       "        0.97797798,  0.99299299,  0.99299299,  0.98998999,  1.        ,\n",
       "        0.995996  ,  0.99399399,  0.99399399,  0.998999  ,  0.99299299,\n",
       "        1.        ,  0.996997  ,  1.        ,  0.98898899,  1.        ,\n",
       "        0.996997  ,  1.        ,  0.99299299,  0.99399399,  0.995996  ,\n",
       "        0.998999  ,  0.98898899,  1.        ,  0.98498498,  0.98098098,\n",
       "        0.99199199,  0.996997  ,  0.98798799,  0.997998  ,  0.998999  ,\n",
       "        0.998999  ,  0.99399399,  0.99099099,  0.99099099,  0.997998  ,\n",
       "        0.99399399,  0.995996  ,  0.99299299,  0.995996  ,  1.        ,\n",
       "        0.995996  ,  0.995996  ,  0.99499499,  1.        ,  0.97997998,\n",
       "        1.        ,  0.99399399,  0.99499499,  0.99499499,  0.98598599,\n",
       "        0.99399399,  0.98198198,  0.998999  ,  0.996997  ,  0.99199199,\n",
       "        0.99199199,  0.98398398,  0.995996  ,  0.99299299,  0.995996  ,\n",
       "        0.99199199,  0.995996  ,  0.997998  ,  0.99499499,  0.998999  ,\n",
       "        0.98098098,  0.998999  ,  1.        ,  0.98898899,  0.99499499,\n",
       "        0.99499499,  1.        ,  1.        ,  0.99299299,  0.98898899,\n",
       "        0.998999  ,  0.99299299,  0.995996  ,  0.997998  ,  0.995996  ,\n",
       "        0.998999  ,  0.998999  ,  0.995996  ,  0.995996  ,  0.98598599,\n",
       "        0.98998999,  0.996997  ,  0.998999  ,  0.998999  ,  0.99499499,\n",
       "        1.        ,  0.995996  ,  0.997998  ,  0.995996  ,  0.99499499,\n",
       "        0.997998  ,  1.        ])"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "np.sum(H_inc==0, axis=1) / float(H_inc.shape[1])"
   ]
  }
 ],
 "metadata": {
  "anaconda-cloud": {},
  "kernelspec": {
   "display_name": "Python [default]",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
